Sign in

CIK 0001447028 · Non-accelerated filer<br>Smaller reporting company

Arbutus Biopharma Corp

Sign in to watch
Ticker
ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
EIN
980597776
Phone
604-419-3200
Business address
701 VETERANS CIRCLE, WARMINSTER, PA, 18974
Former names
TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
  1. 8-K Event Other events
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 8-K Event Other events
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. 4 Returned to the company Director returned 17,948 shares (to the company)
  8. 4 Returned to the company Chief Financial Officer returned 48,081 shares (to the company)
  9. 4 Returned to the company Director returned 17,142 shares (to the company)
  10. 4 Returned to the company President and CEO returned 24,655 shares (to the company)
  11. SCHEDULE 13D/A Stake Beneficial Ownership Report
  12. 4 Returned to the company Director returned 8,967,383 shares (to the company)
  13. SC TO-I/A Deal Tender Offer Statement by Issuer
  14. SC TO-I/A Deal Tender Offer Statement by Issuer
  15. 4 Shares withheld for taxes President and CEO gave up 82,527 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 206,637 shares (to pay taxes)
  17. 4 Shares withheld for taxes Director gave up 100,508 shares (to pay taxes)
  18. 4 Shares withheld for taxes Director gave up 99,057 shares (to pay taxes)
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. SC TO-I Deal Tender Offer Statement by Issuer

Page 1 of 53 · 1,051 filings